Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Locally Advanced Cervical Cancer × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 63 Carcinoma, Non-Small-Cell Lung 54 Breast Neoplasms 30 Nasopharyngeal Carcinoma 25 Lung Neoplasms 24 Urinary Bladder Neoplasms 21 Ovarian Neoplasms 17 Neoplasm Metastasis 17 Cholangiocarcinoma 14 Uterine Cervical Neoplasms 12 Lymphoma, Large B-Cell, Diffuse 12 Gallbladder Neoplasms 12 Biliary Tract Neoplasms 12 Triple Negative Breast Neoplasms 11 Neoplasms 11 Recurrence 10 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Non-Muscle Invasive Bladder Neoplasms 9 Carcinoma, Transitional Cell 9 Nasopharyngeal Neoplasms 7 Fallopian Tube Neoplasms 7 Carcinoma 7 Bile Duct Neoplasms 7 Lymphoma, Non-Hodgkin 6 Lymphoma 6 Adenocarcinoma 5 Urothelial Cancer 3 Neoplasms by Site 3 Lymphoma, T-Cell, Peripheral 3 Endocrine Gland Neoplasms 3

Interventions

Cisplatin 3 durvalumab 1 Gemcitabine 1 Carboplatin 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06156514 2025-05-28

MICHELE

National Institute of Cancerología

Phase 3 Recruiting

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡